Guardant Health Director Alex M. Azar II Acquires Shares via RSU Vesting
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filed for Guardant Health, Inc. ($GH) Insider: Alex M. Azar II (Director) Transaction: Acquisition via RSU Vesting (Code M) Shares: +1,651 @ $0.00 Total Value: $0.00 Direct Holdings Post-Transaction: 1,651 shares Date of Transaction: 2026-09-12
Comprehensive Analysis
Executive Summary
On September 14, 2026, Guardant Health, Inc. ($GH) filed a Form 4 on behalf of Director Alex M. Azar II. The report details the vesting and settlement of 1,651 Restricted Stock Units (RSUs) into Common Stock on September 12, 2026.
Transaction Analysis
- Nature of Transaction: Code M (Exercise or conversion of derivative security). 1,651 RSUs vested and converted into direct ownership of 1,651 shares of common stock at an exercise/conversion price of $0.00.
- Significance: Low. This is a routine scheduled vesting event under a grant awarded on September 12, 2025 (vesting 25% after one year and the remainder monthly over three years). No open market sales or purchases took place.
- Holdings Overview: Following the vesting, Alex M. Azar II directly holds 1,651 common shares and 4,953 remaining unvested RSUs.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.